-
1 Comment
GuangYuYuan Chinese Herbal Medicine Co., Ltd is currently in a long term uptrend where the price is trading 106.5% above its 200 day moving average.
From a valuation standpoint, the stock is 14.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
GuangYuYuan Chinese Herbal Medicine Co., Ltd's total revenue sank by 18.7% to $254M since the same quarter in the previous year.
Its net income has dropped by 62.1% to $21M since the same quarter in the previous year.
Finally, its free cash flow grew by 17.4% to $-44M since the same quarter in the previous year.
Based on the above factors, GuangYuYuan Chinese Herbal Medicine Co., Ltd gets an overall score of 3/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000MY1 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Market Cap | 8B |
|---|---|
| PE Ratio | 132.15 |
| Target Price | None |
| Beta | 0.45 |
| Dividend Yield | None |
GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional and fine Chinese medicines, as well as health wines. It provides its products in the form of pills, powders, tablets, hard capsules, granules, oral liquids, decoctions, and wines. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its name to GuangYuYuan Chinese Herbal Medicine Co., Ltd. in July 2013. GuangYuYuan Chinese Herbal Medicine Co., Ltd. was founded in 1541 and is based in Xi'an, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600771.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
